Sponsor Check › Person
Related person on Form D filings · address states as listed: UT, WA · listed Mar 16, 2009 → Feb 13, 2026
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:56 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
3 of 50 offerings report sales commissions totalling $189,500; 1 reports finder's fees totalling $8,132; 10 report proceeds to related persons totalling $7,411,647. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Feb 13, 2026 D File 021-573472 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 14, 2025 D/A File 021-508086 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 7, 2025 D File 021-537617 | $0 | $0 | $1,000,000 (est.) | None listed on this filing |
| EDGAR ↗ | Feb 7, 2025 D File 021-537620 | $0 | $0 | $1,000,000 (est.) | None listed on this filing |
| EDGAR ↗ | Feb 7, 2025 D File 021-537621 | $0 | $0 | $1,000,000 (est.) | None listed on this filing |
| EDGAR ↗ | Jul 18, 2023 D File 021-487256 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 7, 2023 D File 021-486171 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 21, 2023 D File 021-476513 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 18, 2022 D File 021-465225 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Nov 18, 2022 D File 021-465226 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Nov 16, 2022 D File 021-464916 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jan 21, 2022 D/A File 021-392144 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 22, 2021 D/A File 021-350319 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Feb 6, 2020 D File 021-359961 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 3, 2019 D File 021-341014 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 12, 2017 D File 021-300466 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 2, 2015 D File 021-250479 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 16, 2015 D/A File 021-229573 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 31, 2014 D File 021-231146 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 4, 2013 D File 021-207342 | $0 | $0 | $0 (est.) Proceeds will be used to fund the company's business, including payment of wages to officers and directors. Amount that will be used for this purpose depends on if and when the the company is cash flow positive. | None listed on this filing |
| EDGAR ↗ | Nov 8, 2013 D File 021-206056 | $6,000 (est.) | $0 | $0 | Andrew Laver BrokerCheck CRD 4971312 ↗ |
| EDGAR ↗ | Jun 10, 2013 D File 021-197721 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Apr 25, 2013 D/A File 021-162697 | $83,500 | $8,132 (est.) | $1,015,647 (est.) Consists of approximate amount of ordinary compensation paid or expected to be paid to officers since December 2010 and payable through 2013, and $17,500 in consulting fees payable to a director | Pharus Securities, LLC BrokerCheck CRD 148002 ↗ via MIchael Goodman (CRD 5582359 ↗) Bendigo Securities, LLC BrokerCheck CRD 152529 ↗ |
| EDGAR ↗ | Apr 19, 2013 D File 021-195238 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Mar 12, 2013 D File 021-193130 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Mar 1, 2013 D File 021-192628 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 19, 2013 D File 021-192033 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jan 23, 2013 D File 021-190611 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 6, 2012 D File 021-187976 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Aug 15, 2012 D File 021-182798 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jul 23, 2012 D File 021-181638 | $100,000 | $0 | $0 | GSV Advisors, LLC BrokerCheck CRD 150442 ↗ via North Point Advisors, LLC (CRD 133300 ↗) |
| EDGAR ↗ | Dec 22, 2011 D File 021-170596 | $0 | $0 | $1,600,000 (est.) | None listed on this filing |
| EDGAR ↗ | Nov 18, 2011 D File 021-168978 | $0 | $0 | $96,000 (est.) | None listed on this filing |
| EDGAR ↗ | Sep 27, 2011 D File 021-166420 | $0 | $0 | $350,000 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 29, 2011 D File 021-162022 | $0 | $0 | $460,000 (est.) | None listed on this filing |
| EDGAR ↗ | May 11, 2011 D/A File 021-149543 | $0 | $0 | $550,000 (est.) | None listed on this filing |
| EDGAR ↗ | Apr 8, 2011 D File 021-158099 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 9, 2011 D File 021-155086 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 9, 2011 D File 021-155087 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 23, 2010 D File 021-143874 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 22, 2010 D File 021-143862 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 14, 2010 D File 021-140577 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jan 19, 2010 D/A File 021-121647 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 23, 2009 D File 021-137137 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 20, 2009 D/A File 021-112719 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 20, 2009 D/A File 021-124697 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 26, 2009 D File 021-61411 | $0 | $0 | $340,000 (est.) | None listed on this filing |
| EDGAR ↗ | Apr 30, 2009 D/A File 021-93741 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 16, 2009 D/A File 021-107723 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 16, 2009 D/A File 021-107700 | $0 | $0 | $0 (est.) The General Partner (or its affiliates) is entitled to receive an annual management fee in an amount equal to a specified percentage of assets under management. | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Feb 13, 2026 | D | $1,000,000 similar: $1,100,015–$10,001,163 | $0 | 0 similar: 2–14 | $25,000 similar: $5,000–$50,000 |
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Apr 14, 2025 | D/A | $2,500,000 similar: $1,100,015–$10,001,163 | $1,072,000 | 19 similar: 2–14 | $25,000 similar: $5,000–$50,000 |
| EDGAR ↗ | Second Heart Assist, Inc. | Director | Feb 7, 2025 | D | Indefinite similar: $2,000,000–$19,999,994 | $16,978,238 | 277 similar: 2–16 | $1,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Second Heart Assist, Inc. | Director | Feb 7, 2025 | D | Indefinite similar: $2,000,000–$19,999,994 | $18,303,838 | 284 similar: 2–16 | $1,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Second Heart Assist, Inc. | Director | Feb 7, 2025 | D | Indefinite similar: $2,000,000–$19,999,994 | $17,803,838 | 283 similar: 2–16 | $1,000 similar: $10,000–$50,000 |
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Oct 23, 2024 | D/A | $1,500,000 similar: $1,100,015–$10,001,163 | $1,072,000 | 19 similar: 2–14 | $25,000 similar: $5,000–$50,000 |
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Mar 20, 2024 | D | $1,000,000 similar: $1,100,015–$10,001,163 | $150,000 | 2 similar: 2–14 | $25,000 similar: $5,000–$50,000 |
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Jul 18, 2023 | D | $2,000,000 similar: $500,000–$5,000,000 | $505,000 | 7 similar: 2–15 | $25,000 similar: $6,225–$50,000 |
| EDGAR ↗ | Applied Biosensors, Inc.\DE | Director | Jul 7, 2023 | D | $7,999,999 similar: $1,100,015–$10,001,163 | $674,999 | 1 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Xenocor, Inc. | Director | Mar 21, 2023 | D | $10,000,000 similar: $829,831–$9,999,998 | $4,957,167 | 89 similar: 2–15 | $12,500 similar: $10,000–$54,310 |
| EDGAR ↗ | Second Heart Assist, Inc. | Director | Nov 18, 2022 | D | Indefinite similar: $2,000,000–$19,999,994 | $2,020,461 | 61 similar: 2–16 | $1,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Second Heart Assist, Inc. | Director | Nov 18, 2022 | D | Indefinite similar: $2,000,000–$19,999,994 | $4,334,867 | 106 similar: 2–16 | $1,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Second Heart Assist, Inc. | Director | Nov 16, 2022 | D | Indefinite similar: $2,000,000–$19,999,994 | $14,673,782 | 258 similar: 2–16 | $1,000 similar: $10,000–$50,000 |
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Jan 21, 2022 | D/A | $5,024,921 similar: $500,000–$5,000,000 | $5,024,921 | 25 similar: 2–15 | $25,000 similar: $6,225–$50,000 |
| EDGAR ↗ | Second Heart Assist, Inc. | Director | Apr 22, 2021 | D/A | Indefinite similar: $2,000,000–$19,999,994 | $8,621,204 | 211 similar: 2–16 | $1,000 similar: $10,000–$50,000 |
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Apr 13, 2021 | D/A | $3,949,921 similar: $500,000–$5,000,000 | $3,949,921 | 23 similar: 2–15 | $25,000 similar: $6,225–$50,000 |
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Mar 12, 2021 | D | $1,500,000 similar: $500,000–$5,000,000 | $0 | 0 similar: 2–15 | $25,000 similar: $6,225–$50,000 |
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Feb 6, 2020 | D | $3,000,000 similar: $500,000–$5,000,000 | $0 | 0 similar: 2–15 | No minimum reported similar: $6,225–$50,000 |
| EDGAR ↗ | EKA SOLUTIONS, INC. | Director | Jun 3, 2019 | D | $1,775,000 similar: $500,000–$5,000,000 | $1,775,000 | 19 similar: 2–15 | No minimum reported similar: $6,225–$50,000 |
| EDGAR ↗ | JSK Therapeutics, Inc. | Director | Dec 12, 2017 | D | $1,012,835 similar: $1,100,015–$10,001,163 | $962,839 | 10 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Tute Genomics, Inc. | Director | Nov 2, 2015 | D | $918,531 | $868,532 | 1 | No minimum reported |
| EDGAR ↗ | Tute Genomics, Inc. | Director | Jul 16, 2015 | D/A | $4,250,000 similar: $1,100,015–$10,001,163 | $3,923,267 | 15 similar: 2–14 | $5,000 similar: $5,000–$50,000 |
| EDGAR ↗ | Jade Therapeutics, Inc. | Director | Dec 31, 2014 | D | $800,000 | $0 | 0 | No minimum reported |
| EDGAR ↗ | Tute Genomics, Inc. | Director | Dec 5, 2014 | D | $3,000,000 similar: $1,100,015–$10,001,163 | $2,263,287 | 10 similar: 2–14 | $5,000 similar: $5,000–$50,000 |
| EDGAR ↗ | Juneau Biosciences, LLC | Director | Dec 4, 2013 | D | $11,500,000 similar: $2,000,000–$14,000,000 | $25,000 | 1 similar: 1–19 | $25,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Jade Therapeutics, Inc. | Director | Nov 8, 2013 | D | $600,000 | $0 | 0 | No minimum reported |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Jun 10, 2013 | D | $50,000 similar: $829,831–$9,999,998 | $50,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | LineaGen, Inc | Director | Apr 25, 2013 | D/A | $25,000,000 similar: $829,831–$9,999,998 | $11,594,064 | 16 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Apr 19, 2013 | D | $100,000 similar: $829,831–$9,999,998 | $100,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | LineaGen, Inc | Director | Apr 5, 2013 | D/A | $25,000,000 similar: $829,831–$9,999,998 | $11,594,064 | 16 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | LineaGen, Inc | Director | Apr 5, 2013 | D/A | $25,000,000 similar: $829,831–$9,999,998 | $11,594,064 | 16 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Mar 12, 2013 | D | $200,000 similar: $829,831–$9,999,998 | $200,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | LineaGen, Inc | Director | Mar 1, 2013 | D | $1,000,000 similar: $829,831–$9,999,998 | $150,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Feb 19, 2013 | D | $120,000 similar: $829,831–$9,999,998 | $120,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Jan 23, 2013 | D | $120,000 similar: $829,831–$9,999,998 | $60,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Dec 6, 2012 | D | $200,000 similar: $829,831–$9,999,998 | $200,000 | 4 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Aug 15, 2012 | D | $600,000 similar: $829,831–$9,999,998 | $300,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Graduation Alliance Inc | Director | Jul 23, 2012 | D | $7,971,043 similar: $500,000–$7,000,000 | $5,819,384 | 9 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | LineaGen, Inc | Director | Jun 1, 2012 | D/A | $25,000,000 similar: $829,831–$9,999,998 | $3,600,000 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | EXAGEN INC. | Director | Dec 22, 2011 | D | $24,709,488 similar: $2,000,000–$19,999,994 | $11,986,707 | 9 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | EXAGEN INC. | Director | Nov 18, 2011 | D | $1,000,000 similar: $2,000,000–$19,999,994 | $1,000,000 | 4 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | EXAGEN INC. | Director | Sep 27, 2011 | D | $6,450,000 similar: $2,000,000–$19,999,994 | $4,910,423 | 8 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | LineaGen, Inc | Director | Jul 12, 2011 | D | $3,600,000 similar: $829,831–$9,999,998 | $3,600,000 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | EXAGEN INC. | Director | Jun 29, 2011 | D | $5,799,998 similar: $2,000,000–$19,999,994 | $4,910,490 | 8 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | EXAGEN INC. | Director | May 11, 2011 | D/A | $5,427,984 similar: $2,000,000–$19,999,994 | $5,427,984 | 17 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Graduation Alliance Inc | Director | Apr 8, 2011 | D | $750,001 similar: $500,000–$7,000,000 | $750,001 | 3 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Feb 9, 2011 | D | $5,000,000 similar: $829,831–$9,999,998 | $1,500,000 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Feb 9, 2011 | D | $1,000,000 similar: $829,831–$9,999,998 | $1,000,000 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | EXAGEN INC. | Director | Oct 25, 2010 | D | $3,548,404 similar: $2,000,000–$19,999,994 | $1,999,995 | 10 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | LineaGen, Inc | Director | Jun 23, 2010 | D | $5,012,787 similar: $829,831–$9,999,998 | $5,012,787 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | LineaGen, Inc | Director | Jun 22, 2010 | D | $3,500,000 similar: $829,831–$9,999,998 | $1,100,000 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Director | Apr 14, 2010 | D | $2,000,000 similar: $829,831–$9,999,998 | $1,000,000 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | VSPRING III (SP) LP group: Vspring | Executive Officer | Jan 19, 2010 | D/A | $35,000,000 similar: $155,000–$5,250,000 | $35,000,000 | 3 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Graduation Alliance Inc | Director | Dec 23, 2009 | D | $5,860,751 similar: $500,000–$7,000,000 | $3,260,750 | 6 similar: 2–14 | $1,264 similar: $5,000–$50,000 |
| EDGAR ↗ | vSpring Partners III, L.P. group: Vspring | Executive Officer | Nov 20, 2009 | D/A | $700,000 | $700,000 | 4 | No minimum reported |
| EDGAR ↗ | VSPRING II GROWTH FUND LP group: Vspring | Executive Officer | Nov 20, 2009 | D/A | $39,600,000 similar: $155,000–$5,250,000 | $39,600,000 | 6 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | EXAGEN INC. | Director | May 26, 2009 | D | $2,000,000 similar: $2,000,000–$19,999,994 | $1,000,000 | 15 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Mirabilis Medica, Inc. | Executive Officer | Apr 30, 2009 | D/A | $14,500,000 similar: $500,000–$7,000,000 | $11,666,667 | 9 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Alta Growth Capital Mexico Feeder Fund I LP group: Alta | Executive Officer Managing Member of the Sole Member of the General Partner of the General Partner of the Issuer | Mar 16, 2009 | D/A | $50,000,000 similar: $155,000–$5,250,000 | $30,000,000 | 1 similar: 4–27 | $5,000,000 similar: $1,000–$100,000 |
| EDGAR ↗ | Alta Growth Capital Mexico Fund LP group: Alta | Executive Officer Managing Member of the Sole Member of the General Partner of the General Partner of the Issuer | Mar 16, 2009 | D/A | $150,000,000 similar: $155,000–$5,250,000 | $62,000,000 | 5 similar: 4–27 | $5,000,000 similar: $1,000–$100,000 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (7 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Dinesh Patel. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Dinesh Patel appears on a new Form D, or when a court case or SEC action is matched to them. See plans →